UNITED STATES
                    SECURITIES AND EXCHANGE COMMISSION
                        Washington, D.C.  20549
                              SCHEDULE 13D/A


                 Under the Securities Exchange Act of 1934
                            (Amendment No. 1)*


                           AEHR TEST SYSTEMS
-----------------------------------------------------------------------
                            (Name of Issuer)

                              Common Stock
-----------------------------------------------------------------------
                    (Title of Class of Securities)

                                00760J108
-----------------------------------------------------------------------
                              (CUSIP Number)

                             Gayn Erickson
                          C/O Aehr Test Systems
                             400 Kato Terrace
                            Fremont, CA 94539
                              (510-623-9400)
-----------------------------------------------------------------------
            (Name, Address and Telephone Number of Person
           Authorized to Receive Notices and Communications)


                            April 19, 2017
-----------------------------------------------------------------------
           (Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G
to report the acquisition that is the subject of this Schedule 13D,
and is filing this schedule because of the Sections 240.13d-1(e),
240.13d-1(f) or 240.13d-1(g), check the following box: / /

Note: Schedules filed in paper format shall include a signed original
and five copies of the schedule, including all exhibits.  See Rule
240.13d-7 for other parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the
Securities Exchange Act of 1934 ("Act") or otherwise subject to the
liabilities of that section of the Act but shall be subject to all
other provisions of the Act (however, see the Notes).



                              SCHEDULE 13D/A

CUSIP No. 00760J108
-----------------------------------------------------------------------
  (1)  NAME OF REPORTING PERSON/I.R.S. IDENTIFICATION NO. OF ABOVE
       PERSON

       Gayn Erickson
-----------------------------------------------------------------------
  (2)  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       (a)  / /
       (b)  /x/
-----------------------------------------------------------------------
  (3)  SEC USE ONLY
-----------------------------------------------------------------------
  (4)  SOURCE OF FUNDS (See Instructions)

       PF
-----------------------------------------------------------------------
  (5)  CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
       ITEMS 2(d) OR 2(e) / /
-----------------------------------------------------------------------
  (6)  CITIZENSHIP OR PLACE OF ORGANIZATION

       United States of America
-----------------------------------------------------------------------
Number of                  (7)  SOLE VOTING POWER  924,580
Shares                     --------------------------------------------
Beneficially               (8)  SHARED VOTING POWER   0
Owned by                   --------------------------------------------
Each                       (9)  SOLE DISPOSITIVE POWER  924,580
Reporting                  --------------------------------------------
Person With                (10) SHARED DISPOSITIVE POWER   0
-----------------------------------------------------------------------
 (11)  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       924,580
-----------------------------------------------------------------------
 (12)  CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
       SHARES (See Instructions)  / /
-----------------------------------------------------------------------
 (13)  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 4.2%
-----------------------------------------------------------------------
 (14)  TYPE OF REPORTING PERSON (See Instructions)
       IN
-----------------------------------------------------------------------






Explanatory Note

This Amendment No. 1 (the "Amendment") amends and supplements the Schedule
13D (the "Statement") filed with the Securities and Exchange Commission (the
"SEC") on December 15, 2014, by Gayn Erickson ("Mr. Erickson") with respect to
the common stock, par value $0.01 per share (the "Common Stock"), of Aehr
Test Systems, a California corporation (the "Issuer"). Information reported
in the Statement remains in effect except to the extent that it is amended,
restated or superseded by information contained in this Amendment.

The date of event which requires filing of this Amendment was due to the
issuance of additional shares of Common Stock by the Issuer in a public
offering transaction on April 19, 2017 as previously reported with the SEC on
a Form 8-K filed on April 19, 2017 as the shares issued in the public
offering subsequently reduced the percentage of Common Stock owned by Mr.
Erickson. As of the date hereof, Mr. Erickson has ceased to be a beneficial
owner of more than five percent of the class of securities, and the number of
shares and percentage owned of Common Stock reported in this Amendment are as
of the date of filing of this Amendment.

Item 5 of the Statement is hereby amended and supplemented as follows:

Item 5.  Interest in Securities of the Issuer

       (a) The aggregate percentage of Common Stock reported to be
           owned by the Reporting Persons is based upon 21,894,101
           shares of Common Stock outstanding, which is the total
           number of shares outstanding as of this filing date, and
           assumes the exercise of the 597,027 options held by Mr.
           Erickson which are exercisable within 60 days of this
           filing date, and 890 shares of restricted stock units,
           or RSUs, which are vested within 60 days of this filing
           date.

           Mr. Erickson may be deemed to beneficially own in the
           aggregate 924,580 shares of Common Stock, representing
           approximately 4.2% of the outstanding shares of Common
           Stock.

       (b) Mr. Erickson owns 326,663 shares of Common Stock directly,
           597,027 options to purchase shares of Common stock
           which are exercisable within 60 days of this filing date,
           and 890 shares of RSUs which are vested within 60 days of
           this filing date.

       (c) None.

       (d) No person other than Mr. Erickson, has the right to receive
           or the power to direct the receipt of dividends from, or the
           proceeds from the sale of, the shares of Common Stock set
           forth above.

       (e) Not applicable







                                SIGNATURE

After reasonable inquiry and to the best of each of the undersigned's
knowledge and belief, each of the undersigned, severally and not
jointly, certifies that the information set forth in this statement is
true, complete and correct.


Dated: April 27, 2017

                                         GAYN ERICKSON.

                                         By: /S/ Gayn Erickson
                                         ------------------------
                                         Name: Gayn Erickson